These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33412810)

  • 1. Evaluating a SARS-CoV-2 screening strategy based on serological tests.
    Baccini M; Mattei A; Rocco E; Vannucci G; Mealli F
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):193-199. PubMed ID: 33412810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of over-diagnosis in serological testing. Implications for communications strategies.
    Biggeri A; Forni S; Braga M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):184-192. PubMed ID: 33412809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.
    Jakobsen KK; Jensen JS; Todsen T; Tolsgaard MG; Kirkby N; Lippert F; Vangsted AM; Martel CJ; Klokker M; von Buchwald C
    Dan Med J; 2021 Jun; 68(7):. PubMed ID: 34169830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical symptoms, SARS-CoV-2 test results and immunisation rates in 456 residents from eight nursing homes facing a COVID-19 outbreak.
    Blain H; Gamon L; Tuaillon E; Pisoni A; Giacosa N; Albrand M; Miot S; Rolland Y; Picot MC; Bousquet J
    Age Ageing; 2021 May; 50(3):641-648. PubMed ID: 33620381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
    Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.
    Savirón-Cornudella R; Villalba A; Zapardiel J; Andeyro-Garcia M; Esteban LM; Pérez-López FR
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():400-404. PubMed ID: 33285496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro diagnostics of coronavirus disease 2019: Technologies and application.
    Lai CC; Wang CY; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2021 Apr; 54(2):164-174. PubMed ID: 32513617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.
    Bouman JA; Riou J; Bonhoeffer S; Regoes RR
    PLoS Comput Biol; 2021 Feb; 17(2):e1008728. PubMed ID: 33635863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak.
    McKay SL; Tobolowsky FA; Moritz ED; Hatfield KM; Bhatnagar A; LaVoie SP; Jackson DA; Lecy KD; Bryant-Genevier J; Campbell D; Freeman B; Gilbert SE; Folster JM; Medrzycki M; Shewmaker PL; Bankamp B; Radford KW; Anderson R; Bowen MD; Negley J; Reddy SC; Jernigan JA; Brown AC; McDonald LC; Kutty PK;
    Ann Intern Med; 2021 Jul; 174(7):945-951. PubMed ID: 33900791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study.
    Trouillet-Assant S; Albert Vega C; Bal A; Nazare JA; Fascia P; Paul A; Massardier-Pilonchery A; D Aubarede C; Guibert N; Pitiot V; Lahousse M; Boibieux A; Makhloufi D; Simon C; Rabilloud M; Trabaud MA; Gueyffier F; Fassier JB;
    BMJ Open; 2020 Nov; 10(11):e041268. PubMed ID: 33234651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.
    Jiang JC; Zhang Y
    Biochem Soc Trans; 2020 Dec; 48(6):2851-2863. PubMed ID: 33170924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.
    Lanari M; Biserni GB; Pavoni M; Borgatti EC; Leone M; Corsini I; Lazzarotto T
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting.
    Sood N; Shetgiri R; Rodriguez A; Jimenez D; Treminino S; Daflos A; Simon P
    PLoS One; 2021; 16(4):e0249710. PubMed ID: 33819311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].
    Pardo Lledias J; Ayarza L; González-García P; Salmón González Z; Calvo Montes J; Gozalo Marguello M; Hernández Hernández JL; Olmos Martínez JM
    Rev Esp Quimioter; 2020 Dec; 33(6):410-414. PubMed ID: 32935535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Adding IgM Antibody to Polymerase Chain Reaction Testing Useful for COVID-19 Travel Screening?
    Yi X; Chan CW; Yeo KJ
    Am J Clin Pathol; 2021 Feb; 155(3):321-323. PubMed ID: 33399188
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting.
    Osterman A; Baldauf HM; Eletreby M; Wettengel JM; Afridi SQ; Fuchs T; Holzmann E; Maier A; Döring J; Grzimek-Koschewa N; Muenchhoff M; Protzer U; Kaderali L; Keppler OT
    Med Microbiol Immunol; 2021 Feb; 210(1):65-72. PubMed ID: 33452927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater public health impact of COVID-19 antigen detection tests.
    Kowada A
    BMC Med; 2021 Mar; 19(1):82. PubMed ID: 33757504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.